Hôpital civil, Strasbourg

Strasbourg 67091

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, MDS, Myelodysplastic Syndrome, Prevention of Stroke or Systemic Embolism, RAEB, Refractory Anemia With Excess Blasts

Studies at this site

• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early